SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-619607
Filing Date
2016-06-13
Accepted
2016-06-13 07:52:10
Documents
5
Effectiveness Date
2016-06-13

Document Format Files

Seq Description Document Type Size
1 8-K d135874d8k.htm DEFA14A 35404
2 EX-10.1 d135874dex101.htm EX-10.1 471407
3 EX-99.1 d135874dex991.htm EX-99.1 11963
4 EX-99.2 d135874dex992.htm EX-99.2 7324
5 GRAPHIC g135874g61o46.jpg GRAPHIC 8708
  Complete submission text file 0001193125-16-619607.txt   539256
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 161709885
SIC: 2834 Pharmaceutical Preparations